{"schema_version":"secwatch.filing_event.v1","accession":"0001420720-24-000032","form_type":"8-K","ticker":"IBIO","cik":"0001420720","company_name":"iBio, Inc.","filed_at":"2024-07-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.001245+00:00","generated_at":"2026-05-31T15:56:55.010177+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"iBio amends CEO Martin Brenner's agreement; base salary $522K, bonus target raised to 50% for FY2025","bullets":["Base salary set at $522,365; FY2025 bonus target increased to 50% of base salary, FY2024 remains 40%.","Severance without cause or for good reason includes 12 months salary, pro-rata bonus, and COBRA coverage.","Upon Sale Event termination: 18 months salary, target bonus, and accelerated vesting of time-vested equity.","Employment is at-will; includes standard termination benefits and non-solicitation/invention assignment clauses."],"urls":{"canonical":"https://secwatch.observer/filing/0001420720-24-000032","json":"https://secwatch.observer/filing/0001420720-24-000032.json","markdown":"https://secwatch.observer/filing/0001420720-24-000032.md","text":"https://secwatch.observer/filing/0001420720-24-000032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1420720/000142072024000032/0001420720-24-000032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1420720/000142072024000032/ibio-20240723x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:56:55.010177+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}